|
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine |
|
CHEBI:79097 |
|
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine |
|
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as hexadecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C43H74NO8P/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-26-28-30-32-34-36-43(46)52-41(40-51-53(47,48)50-38-37-44)39-49-42(45)35-33-31-29-27-25-23-16-14-12-10-8-6-4-2/h5,7,11,13,17-18,20-21,24,26,30,32,41H,3-4,6,8-10,12,14-16,19,22-23,25,27-29,31,33-40,44H2,1-2H3,(H,47,48)/b7-5-,13-11-,18-17-,21-20-,26-24-,32-30-/t41-/m1/s1 |
MPWUZHVZZKSTPV-MADBQMNMSA-N |
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC |
|
Outgoing
|
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
(CHEBI:79097)
has functional parent
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid
(CHEBI:28125)
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
(CHEBI:79097)
has functional parent
hexadecanoic acid
(CHEBI:15756)
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
(CHEBI:79097)
is a
1,2-diacyl-sn-glycero-3-phosphoethanolamine
(CHEBI:64674)
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
(CHEBI:79097)
is tautomer of
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:78261)
|
|
Incoming
|
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:78261)
is tautomer of
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
(CHEBI:79097)
|
(19R)-25-amino-22-hydroxy-22-oxido-16-oxo-17,21,23-trioxa-22λ5-phosphapentacosan-19-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
|
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
|
LIPID MAPS
|
1-Hexadecanoyl-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine
|
ChemIDplus
|
1-palmitoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
|
ChEBI
|
1-Palmitoyl-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine
|
ChemIDplus
|
GPEtn(16:0/22:6)
|
HMDB
|
GPEtn(16:0/22:6n3)
|
HMDB
|
GPEtn(16:0/22:6w3)
|
HMDB
|
GPEtn(38:6)
|
HMDB
|
PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
LIPID MAPS
|
PE(16:0/22:6)
|
LIPID MAPS
|
PE(16:0/22:6n3)
|
HMDB
|
PE(16:0/22:6w3)
|
HMDB
|
PE(38:6)
|
HMDB
|
Phophatidylethanolamine(38:6)
|
HMDB
|
Phosphatidylethanolamine(16:0/22:6)
|
HMDB
|
Phosphatidylethanolamine(16:0/22:6n3)
|
HMDB
|
Phosphatidylethanolamine(16:0/22:6w3)
|
HMDB
|
7789266
|
Reaxys Registry Number
|
Reaxys
|
|